FDA Adverse Event Injury Summary report: N

ACCU-CHEK SPIRIT

MDR report key: 3052075 · Received April 11, 2013

Report

Report Number
2183996-2013-00642
Event Type
Injury
Date Received
April 11, 2013
Date of Event
March 28, 2013
Report Date
June 13, 2013
Manufacturer
ROCHE DIABETES CARE AG
Product Code
LZG
PMA / PMN Number
NA
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AR
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE INCIDENT OCCURRED OUTSIDE THE UNITED STATES. INFORMATION CONTAINED WITHIN THIS REPORT IS ALL THAT IS AVAILABLE AT THIS TIME. IF FURTHER INFORMATION IS OBTAINED, IT WILL BE PROVIDED IN THE SUPPLEMENTAL REPORT.

Additional Manufacturer Narrative · 1

THE DELIVERY ACCURACY AND THE OCCLUSION LIMITS WERE TESTED WITHIN THE PUMP DRIVE TEST ON THE DIAGNOSIS TEST AND MEET THE SPECIFICATION. ALL ALARM FUNCTIONS WERE TESTED SUCCESSFUL AND NO MALFUNCTION COULD BE OBSERVED DURING THE TECHNICAL INVESTIGATION. THE TECHNICAL INVESTIGATION GAVE NO EVIDENCE THAT THE DEVICE DID CAUSE OR CONTRIBUTE TO THE CONDITION REPORTED BY THE PATIENT.

Description of Event or Problem · 1

ON (B)(6) 2013, IT WAS REPORTED THAT THE PATIENT WAS IN THE HOSPITAL ON (B)(6) 2013 WITH SYMPTOMS OF HYPERGLYCEMIA; HIS BLOOD GLUCOSE LEVEL WAS 145 MG/DL. HE EXPERIENCED CHEST AND MUSCLE PAIN, VOMITING, AND DIARRHEA. HIS DOCTOR INITIALLY ADMINISTERED 8 UNITS OF INSULIN AND THEN AN ADDITIONAL 6 UNITS OF INSULIN AT A LATER TIME. THE PATIENT WAS IN THE HOSPITAL FOR 6-7 HOURS. WHILE AT THE HOSPITAL IT WAS NOTICED THAT THE CANNULA OF THE PATIENT'S INFUSION SET WAS BENT AND THE INFUSION DEVICE DID NOT DISPLAY ANY ERROR OR ALERT MESSAGE. THE USED INFUSION SET HAD BEEN DISCARDED BY THE PATIENT. THE INFUSION DEVICE WAS REQUESTED TO BE RETURNED FOR PRODUCT EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
156862 ACCU-CHEK SPIRIT INSULIN INFUSION DEVICE LZG ROCHE DIABETES CARE AG 00700006862 NA

Patients

Seq Age Sex Outcome Treatment
1 041 YR Hospitalization| R ENALAPRIL 2.5 MG (1 PER DAY)